ARCHIVES

Caris Life Sciences Lays Off Estimated 20 Percent of Staff

This article is from The Cancer Letter archive.

Vol. 40 No. 40 | October 24, 2014

Download PDF Visit The Full Archive

Related Articles

FDA Approves Votrient For Renal Cell Carcinoma

October 23, 2009

New Tenure Program Begins, NIH May Have 20-30 Positions Open

August 5, 1994

FDA Approves Ixempra For Metastatic Breast Cancer Resistant To Other Therapy

October 26, 2007

NCAB Subcommittee Urges New Centers Categories, Recognition Of More New Comprehensive Centers

March 28, 1975

In Brief: Bristol To Drop Angiostatin; Protein Fails To Meet Criteria For Development, Firm Says

February 12, 1999

Carbone Heads Chairmen’s Group

June 30, 1978